In this role Mr Lowth will be responsible for finance and information services. Mr Lowth joins AstraZeneca from Scottish Power where he was finance director following two years as executive director, corporate strategy and development.
David Brennan, CEO of AstraZeneca, said: “Simon brings to AstraZeneca a track record of delivering good financial results combined with extensive strategy and business development expertise. I am confident that he will be a valuable addition to the senior executive team and an able leader of AstraZeneca’s strong finance team.”
Louis Schweitzer, chairman of AstraZeneca, said: “Simon has unique insight into the dynamics of companies driving change and re-structuring for future success. He put this experience into practice driving the turnaround at Scottish Power, contributing to significant improvements in business and financial performance. AstraZeneca has embarked on its own change journey including the transformational move into large-scale biologics this year, so Simon’s background makes him particularly well-suited to this role.”